Thus, we have improved our understanding of the sepsis transcriptomic subtypes and exposed previously unknown associations between heme metabolism and coagulation underlying CTS2-classified patients, which make up approximately 20% of patients with sepsis studied. The gene discussed is COMP; the disease is Sepsis.